LataMed AI Corp. (OTC: LMED), a development-stage digital health and artificial intelligence technology company, announced today that it is finalizing details for an exclusive interview with Hablemos Seguros & Finanzas, a Venezuelan business, finance, and insurance media platform. The interview is expected to focus on the Company's healthcare technology development initiatives, telehealth infrastructure efforts, and artificial intelligence applications within healthcare environments, as well as its broader strategy for building digital healthcare technologies for emerging markets in Latin America.
The interview is expected to provide management with an opportunity to discuss recent operational developments, healthcare technology initiatives currently under development, and long-term strategy for building technology platforms intended to support patients, providers, and healthcare organizations. The discussion will also highlight the Company's ongoing work related to telehealth infrastructure, healthcare coordination technologies, emergency medical response initiatives, pharmacy integration capabilities, and artificial intelligence-driven healthcare solutions.
Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI Corp., stated: "We believe this interview represents a valuable opportunity to communicate LataMed AI's strategic vision, technology development priorities, and commitment to advancing digital healthcare infrastructure across Latin America. As healthcare systems continue to evaluate technology-enabled models for coordination, access, and efficiency, we remain focused on developing practical solutions designed to support patients, providers, and healthcare organizations in emerging markets."
The Company believes the interview will provide a timely platform to communicate its strategic objectives, increase awareness of its digital healthcare development efforts, and engage with industry participants and the healthcare business community regarding the evolving role of technology-enabled healthcare solutions in Latin America. The discussion is also expected to address the growing role of digital healthcare technologies in healthcare accessibility, patient engagement, operational efficiency, and healthcare coordination throughout the region, as well as the opportunities and challenges associated with technology-enabled healthcare deployment within developing markets.
The interview is expected to occur in the near term, with details regarding timing and publication to be announced once finalized. The Company anticipates that the discussion will be live-streamed through the media platform's digital channels, and that a recording will be made available through the Company's website shortly following its conclusion. Availability, timing, and distribution remain subject to final scheduling and production arrangements.
The interview is intended for informational purposes only and should not be considered an offer to sell or a solicitation to purchase any securities of the Company. For additional information, visit https://latamed.ai or review the Company's filings with the U.S. Securities and Exchange Commission at www.sec.gov.
